Appleby P and Bowen JG |
Cutaneous inflammatory disorders. |
1990 |
Agents Actions |
pmid:2117335
|
Doyle SA et al. |
Further studies on the antinociceptive effects of delta 6-THC-7-oic acid. |
1990 |
Agents Actions |
pmid:2178317
|
Adnot S et al. |
Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. |
1987 |
Agents Actions |
pmid:3115070
|
Morley J |
Platelet activating factor and asthma. |
1986 |
Agents Actions |
pmid:3099555
|
Lauri D et al. |
Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin. |
1986 |
Agents Actions |
pmid:3706054
|
Archer CB et al. |
Actions of disodium cromoglycate (DSCG) on human skin responses to histamine, codeine and Paf-acether. |
1985 |
Agents Actions |
pmid:3923788
|
Page CP et al. |
Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation. |
1985 |
Agents Actions |
pmid:4003195
|
Page CP et al. |
Suppression of Paf-acether responses: an anti-inflammatory effect of anti-asthma drugs. |
1985 |
Agents Actions |
pmid:4003196
|
Spicer BA et al. |
An investigation of the involvement of platelet activating factor in the non-histamine immediate hypersensitivity reaction in the rat peritoneal cavity. |
1985 |
Agents Actions |
pmid:4003197
|
Boughton-Smith NK et al. |
Actions of nitric oxide on the acute gastrointestinal damage induced by PAF in the rat. |
1992 |
Agents Actions |
pmid:1279960
|
Canale P et al. |
TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock. |
1994 |
Agents Actions |
pmid:7879698
|
Denburg JA et al. |
Platelet activating factor: regulation by mast cells and aspirin. |
1984 |
Agents Actions |
pmid:6711391
|
Mencia-Huerta JM et al. |
Is platelet-activating factor (PAF-acether) synthesis by murine peritoneal cells (PC) a two-step process? |
1981 |
Agents Actions |
pmid:7053072
|
Bette P and Bienvenue A |
Exchange of a spin-labeled analog of PAF-acether between micelles, serum albumin and model membranes. |
1982 |
Agents Actions |
pmid:7164940
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of PAF-acether. Preliminary results after the intravenous administration of a 3H-labelled product to the rabbit. |
1982 |
Agents Actions |
pmid:7164941
|
Morgat JL et al. |
Radio-labelling of 1-O-alkyl, 2-O-acetyl, sn-glycero-3-phosphorylcholine, 1-O-(9,10-di3H)-octadecyl PAF-acether. |
1982 |
Agents Actions |
pmid:7164942
|
Convert O et al. |
1H NMR of PAF-acether: influence of solvent on its structure. |
1982 |
Agents Actions |
pmid:7164943
|
Borrel MC et al. |
Additional techniques for the total synthesis of PAF-acether. |
1982 |
Agents Actions |
pmid:7164944
|
Benveniste J et al. |
Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types. |
1982 |
Agents Actions |
pmid:7164945
|
Bonnet J et al. |
Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes. |
1981 |
Agents Actions |
pmid:7340441
|